Provides an overview of tumor microenvironment, the challenges and opportunities in developing stimuli-responsive and site-specific delivery nanoplatforms, and their related strategies for cancer treatment as well as toxicological and regulatory aspects. This illustrates their industrial applicability and commercialization prospects.
Inhaltsverzeichnis
- Nanoparticles and Tumor microenvironment: challenges and opportunities
- Materials and chemistries of tumor microenvironment-responsive delivery platforms
- pH-responsive delivery nanoplatform in cancer theranostics
- Enzyme-responsive delivery nanoplatform in cancer theranostics
- Redox-responsive delivery nanoplatform in cancer theranostics
- ROS-responsive delivery nanoplatform in cancer theranostics
- Hypoxia-responsive delivery nanoplatform in cancer theranostics
- Dual/multi-responsive delivery nanoplatforms in cancer theranostics
- Temperature-responsive delivery nanoplatform in cancer theranostics
- Light-responsive delivery nanoplatform in cancer theranostics
- Magnetic field-responsive delivery nanoplatform in cancer theranostics
- Ultrasound-responsive delivery nanoplatform in cancer theranostics
- Exogenous dual/multi-responsive delivery platforms in cancer theranostics
- Aptamer-based targeting of nanoplatforms for cancer theranostics
- Peptide-based targeting of nanoplatforms for cancer theranostics
- Antibody-based targeting of nanoplatforms for cancer theranostics
- Carbohydrate-based targeting of nanoplatforms for cancer theranostics
- Subcellular targeting of nanoparticles for cancer theranostics
- Characterization techniques for stimuli-responsive delivery nanoplatforms in cancer treatment
- Toxicological aspects of tumor microenvironment-responsive nanoplatforms
- Commercialization challenges of tumor microenvironment-responsive nanoplatforms
